TY  - GEN
AU  - de Jonge,Maja J A
AU  - van der Gaast,Ate
AU  - Planting,André S T
AU  - van Doorn,Leny
AU  - Lems,Aletta
AU  - Boot,Inge
AU  - Wanders,Jantien
AU  - Satomi,Masahiko
AU  - Verweij,Jaap
TI  - Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors
SN  - 1078-0432
PY  - 2005///0823
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Chromatography, High Pressure Liquid
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Infusions, Intravenous
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Neoplasms
KW  - drug therapy
KW  - Oligopeptides
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
UR  - https://doi.org/10.1158/1078-0432.CCR-04-1937
ER  -